The growth of co-transformed cells in the peritoneal cavity alters viral gene expression to mirror that of PEL cell lines. حسب Mitchell Hayes (5334887)

Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

"…Asterisks in panels D and E indicate statistically significant difference relative to wild type, Z-test for proportions (***<i>p</i> < 0.0001). …"

The growth of co-transformed cells in the peritoneal cavity alters their cellular gene expression to mirror that of PEL biopsies. حسب Mitchell Hayes (5334887)

Co-infected cells express both KSHV and EBV genes <i>in vitro</i> necessary for their survival and growth. حسب Mitchell Hayes (5334887)

Loss of RBM-26 causes mitochondria dysfunction in PLM. حسب Tamjid A. Chowdhury (14149846)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... حسب Jinho Lee (587173)

الموضوعات:

Proportion of stillbirths in Stockholm among twin and singleton pregnancies. حسب Matilda Varli Hjärne (22766125)

Table 1_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.docx حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. حسب Tamjid A. Chowdhury (14149846)

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. حسب Daniel P. Bradley (10306893)

Image 5_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.png حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Image 9_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Image 1_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.jpeg حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Image 2_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Image 8_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Image 7_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Image 10_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"

Image 4_Unexpected estradiol decline during ovarian stimulation monitoring affects cumulative live birth.tiff حسب Haixiao Chen (12565087)

"…Unexpected E₂ decline before triggering is reported in monitored COS cycles, yet its clinical significance remains controversial.…"